ES2183142T3 - Bis(acridincarboxamida) y bis (fenezincarboxamida) en calidad de agentes antitumorales. - Google Patents
Bis(acridincarboxamida) y bis (fenezincarboxamida) en calidad de agentes antitumorales.Info
- Publication number
- ES2183142T3 ES2183142T3 ES97909456T ES97909456T ES2183142T3 ES 2183142 T3 ES2183142 T3 ES 2183142T3 ES 97909456 T ES97909456 T ES 97909456T ES 97909456 T ES97909456 T ES 97909456T ES 2183142 T3 ES2183142 T3 ES 2183142T3
- Authority
- ES
- Spain
- Prior art keywords
- bis
- equal
- different
- fenezincarboxamida
- acridincarboxamida
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- AORNIVFSXFONEC-UHFFFAOYSA-N acridine-1-carboxamide Chemical compound C1=CC=C2C=C3C(C(=O)N)=CC=CC3=NC2=C1 AORNIVFSXFONEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Multicomponent Fibers (AREA)
- Polishing Bodies And Polishing Tools (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
LA INVENCION SE REFIERE A UN COMPUESTO QUE ES UN DERIVADO BIS (ACRIDINCARBOXAMIDA) O BIS(FENAZINCARBOXAMIDA) DE FORMULA (I), DONDE CADA X, QUE PUEDE SER IGUAL O DISTINTO EN CADA MOLECULA, ES - CH = O - N =, CADA UNO DE R 1 A R 4 , QUE PUEDE SER IGUAL O DISTINTO, ES H, ALQUILO C 1 - C 4 , OH, SH, NH 2 , ALCOXI C 1 - C 4 , ARILOXI, NHR, N(R 2 ), SR, SO 2 R, DONDE R ES ALQUILO C 1 C 4 , CF 3 , NO 2 O HALOGENO, O R 1 Y R 2 FORMAN CONJUNTAMENTE UN GRUPO METILENDIOXI; CADA UNO DE R 5 Y R 6 , QUE PUEDEN SER IGUALES O DISTINTOS, ES H O ALQUILO C 1 - C 4 ; Z ES (CH 2 ) N , (CH 2 ) N O(CH 2 ) N , (CH 2 ) N N(R 7 ), (CH 2 ) M N(R 7) O (CH 2 ) N N(CH 2 CH 2 ) 2 N(CH 2 ) N , DONDE R 7 ES H O ALQUILO C SUB,1 - C 4 Y N Y M, QUE PUEDEN SER IGUALES O DISTINTOS, SON CADA UNO UN ENTERO DE 1 A 4. SE SUMINISTRA TAMBIEN UNA SAL DE ADICION O N - OXIDO DE DICHO COMPUESTO, EL CUAL ACTUA COMO AGENTE ANTIBACTERIANO Y ANTITUMORAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9621795.5A GB9621795D0 (en) | 1996-10-18 | 1996-10-18 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2183142T3 true ES2183142T3 (es) | 2003-03-16 |
Family
ID=10801674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97909456T Expired - Lifetime ES2183142T3 (es) | 1996-10-18 | 1997-10-17 | Bis(acridincarboxamida) y bis (fenezincarboxamida) en calidad de agentes antitumorales. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6114332A (es) |
| EP (1) | EP0934278B1 (es) |
| JP (1) | JP2001503399A (es) |
| KR (1) | KR20000049252A (es) |
| CN (1) | CN1116285C (es) |
| AT (1) | ATE223381T1 (es) |
| AU (1) | AU717724B2 (es) |
| BG (1) | BG64555B1 (es) |
| BR (1) | BR9711948A (es) |
| CA (1) | CA2268411C (es) |
| CZ (1) | CZ295302B6 (es) |
| DE (1) | DE69715230T2 (es) |
| DK (1) | DK0934278T3 (es) |
| ES (1) | ES2183142T3 (es) |
| GB (2) | GB9621795D0 (es) |
| HU (1) | HU221953B1 (es) |
| ID (1) | ID22444A (es) |
| MY (1) | MY122017A (es) |
| NO (1) | NO313381B1 (es) |
| NZ (1) | NZ335055A (es) |
| PL (1) | PL193669B1 (es) |
| PT (1) | PT934278E (es) |
| RO (1) | RO120636B1 (es) |
| RU (1) | RU2179972C2 (es) |
| SK (1) | SK285121B6 (es) |
| TW (1) | TW432060B (es) |
| UA (1) | UA67729C2 (es) |
| WO (1) | WO1998017650A1 (es) |
| ZA (2) | ZA979331B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974878B2 (en) | 2001-03-21 | 2005-12-13 | Symyx Technologies, Inc. | Catalyst ligands, catalytic metal complexes and processes using same |
| AU6040699A (en) * | 1999-09-10 | 2001-04-17 | Symyx Technologies, Inc. | Catalyst ligands, catalytic metal complexes and processes using and methods of making same |
| JP4718328B2 (ja) * | 2003-12-31 | 2011-07-06 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | Ｃ８連結したピロロ［２，１−ｃ］［１，４］ベンゾジアゼピン−アクリドン／アクリジン・ハイブリッド |
| JP2017500368A (ja) * | 2013-12-24 | 2017-01-05 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | 抗微生物剤としてのフェナジン誘導体 |
| CN104961801B (zh) * | 2015-07-13 | 2018-01-19 | 兰州大学 | 一种具有多靶点的抗菌多肽偶联物及其二聚物的合成和应用 |
| CN106554321B (zh) * | 2015-09-25 | 2019-05-28 | 陆源 | 一种吩嗪类物质、其制备方法及其应用 |
| US20240279204A1 (en) * | 2021-12-09 | 2024-08-22 | Korea Institute Of Ocean Science & Technology | Novel diphenazine compound, and use thereof for preventing or treating cancer or neuroinflammatory diseases |
| WO2025043616A1 (zh) * | 2023-08-31 | 2025-03-06 | 侯明宏 | 吖啶类衍生物用于抗癌的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ201084A (en) * | 1982-06-25 | 1985-10-11 | New Zealand Dev Finance | 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such |
| JPS61112061A (ja) * | 1984-08-16 | 1986-05-30 | デベロツプメント フアイナンス コ−ポレ−シヨン オブニユ−ジ−ランド | 新規なフエナジン誘導体 |
| IT1293525B1 (it) * | 1997-08-01 | 1999-03-01 | Uni Degli Studi Camerino | Bis-acridincarbossiammidi aventi attivita' antitumorale |
-
1996
- 1996-10-18 GB GBGB9621795.5A patent/GB9621795D0/en active Pending
-
1997
- 1997-10-17 ES ES97909456T patent/ES2183142T3/es not_active Expired - Lifetime
- 1997-10-17 EP EP97909456A patent/EP0934278B1/en not_active Expired - Lifetime
- 1997-10-17 NZ NZ335055A patent/NZ335055A/xx unknown
- 1997-10-17 RU RU99109978/04A patent/RU2179972C2/ru not_active IP Right Cessation
- 1997-10-17 GB GB9908192A patent/GB2334032B/en not_active Expired - Lifetime
- 1997-10-17 UA UA99042117A patent/UA67729C2/uk unknown
- 1997-10-17 RO RO99-00433A patent/RO120636B1/ro unknown
- 1997-10-17 CN CN97180614A patent/CN1116285C/zh not_active Expired - Fee Related
- 1997-10-17 ZA ZA9709331A patent/ZA979331B/xx unknown
- 1997-10-17 AT AT97909456T patent/ATE223381T1/de not_active IP Right Cessation
- 1997-10-17 AU AU47137/97A patent/AU717724B2/en not_active Ceased
- 1997-10-17 HU HU9902883A patent/HU221953B1/hu not_active IP Right Cessation
- 1997-10-17 PL PL97332877A patent/PL193669B1/pl not_active IP Right Cessation
- 1997-10-17 US US09/284,623 patent/US6114332A/en not_active Expired - Fee Related
- 1997-10-17 ZA ZA979328A patent/ZA979328B/xx unknown
- 1997-10-17 PT PT97909456T patent/PT934278E/pt unknown
- 1997-10-17 DE DE69715230T patent/DE69715230T2/de not_active Expired - Fee Related
- 1997-10-17 WO PCT/GB1997/002886 patent/WO1998017650A1/en not_active Ceased
- 1997-10-17 CZ CZ19991271A patent/CZ295302B6/cs not_active IP Right Cessation
- 1997-10-17 KR KR1019990703357A patent/KR20000049252A/ko not_active Ceased
- 1997-10-17 ID IDW990196A patent/ID22444A/id unknown
- 1997-10-17 MY MYPI97004914A patent/MY122017A/en unknown
- 1997-10-17 DK DK97909456T patent/DK0934278T3/da active
- 1997-10-17 BR BR9711948A patent/BR9711948A/pt not_active Application Discontinuation
- 1997-10-17 SK SK504-99A patent/SK285121B6/sk unknown
- 1997-10-17 JP JP51910998A patent/JP2001503399A/ja not_active Ceased
- 1997-10-17 CA CA002268411A patent/CA2268411C/en not_active Expired - Fee Related
- 1997-10-18 TW TW086115404A patent/TW432060B/zh not_active IP Right Cessation
-
1999
- 1999-04-13 BG BG103329A patent/BG64555B1/bg unknown
- 1999-04-16 NO NO19991833A patent/NO313381B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE217629T1 (de) | Phosphonooxymethyl oder methylthiomethylether von taxanderivaten als antitumormittel | |
| DK0604910T3 (da) | Phosphonooxymethylethere af taxanderivater | |
| ECSP034600A (es) | Compuestos de lactama | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| MY113806A (en) | Antiparasitic marcfortines and paraherquamides | |
| CY1108848T1 (el) | Εντομοκτονες ανθρανιλαμιδες | |
| EP0731106A4 (en) | Novel peptide derivative | |
| IL139208A0 (en) | Pharmaceutical compositions containing arsenic sulfide derivatives | |
| ECSP044997A (es) | DERIVADOS SUSTITUIDOS DEL INDENO [1,2-c] ISOQUINOLINA | |
| EP1045851A4 (en) | SUBSTITUTED PORPHYRINS | |
| AR245494A1 (es) | Una composicion detergente. | |
| ES2103289T3 (es) | Derivados de pirimidina y composiciones herbicidas que los contienen. | |
| ES2153076T3 (es) | Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos. | |
| DE59708265D1 (de) | Neue in 6-position substituierte phenanthridine | |
| ES2188984T3 (es) | Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas. | |
| DE59913339D1 (de) | Verfahren zur herstellung von derivaten des polyarylenvinylen | |
| ATE183747T1 (de) | Halogen-freie, cyclische, phosphor enthaltende flammenhemmende verbindungen | |
| IS1639B (is) | Hliðstæð aðferð til að framleiða ný antihistamín,sem ekki hafa róandi áhrif, leidd af benzimidazole efnum | |
| ES2157899T3 (es) | Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos. | |
| BG101109A (bg) | Пиридилтио-съединения,метод за получаването им иприложението им за борба с бактерии от рода хеликобактер | |
| AR009120A1 (es) | Una composicion de grasa de urea y mecanismos que contienen tal composicion | |
| ES2186799T3 (es) | Bencimidazoles sustituidos en 5' utilizados como agentes antivirales. | |
| DE69724472D1 (de) | Selenophen-antitumormittel | |
| DE60006063D1 (de) | Bis-terpyridinplatinkomplexe | |
| MY122950A (en) | Photochromic oxazine compounds and methods for their manufacture |